Sam Altman says OpenAI will embrace two new AI approaches, one from DeepSeek and another from Meta Federal employees ordered to remove pronouns from their email signature and urged to find ‘higher ...

Vertex to see decline in earnings but double-digit revenue growth with new drug JOURNAVX and CF franchise expansion, positioning for long-term growth.

You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...

The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.

A new non-opioid painkiller, JournaVX, has received approval from the FDA, marking the first new type of pain medication in ...

Many public health experts warn of the additive qualities of powerful opioid painkillers. One pharmaceutical company is revealing its new pill that it says does away with those dangers.

The Food and Drug Administration announced Thursday its approval of suzetrigine, the first new painkiller greenlit by the ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

The FDA has approved suzetrigine, a new, non-opioid medication for adults with moderate to severe acute pain.

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...